The preclinical pharmacological profile of the potent and selective leukotriene B4 antagonist CP-195543.
Showell HJ, Conklyn MJ, Alpert R, Hingorani GP, Wright KF, Smith MA, Stam E, Salter ED, Scampoli DN, Meltzer S, Reiter LA, Koch K, Piscopio AD, Cortina SR, Lopez-Anaya A, Pettipher ER, Milici AJ, Griffiths RJ.
Showell HJ, et al.
J Pharmacol Exp Ther. 1998 Jun;285(3):946-54.
J Pharmacol Exp Ther. 1998.
PMID: 9618393